GH peptides for fat loss

The honest answer: GH peptides help fat loss, but not the way most people hope. They are not a fat-loss drug. They are a body-composition support tool that, layered on top of an actual deficit, helps you keep more muscle and reduce more fat — particularly visceral fat — than you would without them. If you're hoping to lose weight without changing diet or training, GH peptides are the wrong tool.

How GH affects fat tissue

Growth hormone has direct lipolytic effects on adipose tissue. The mechanism is well-characterized:

• GH binds GH receptors on adipocytes
• Activates hormone-sensitive lipase
• Releases free fatty acids from storage
• Particularly active on visceral adipose (more GH receptors than subcutaneous fat)

In a calorie deficit, this means more of the fat you lose comes from stubborn visceral stores. In maintenance or surplus, it means a slightly leaner body composition at the same weight. The effect is real but modest — not in the ballpark of a stimulant fat-burner, definitely not in the ballpark of a GLP-1 weight-loss drug.

Why secretagogues are not standalone fat-loss tools

Three reasons:

1. The GH effect on fat is dose-limited. Secretagogues cap at the pituitary's release ceiling. You can't just push the dose higher to get more lipolysis.
2. There's no appetite suppression. GHRP-6 actually increases appetite. Ipamorelin is neutral. None of the GH peptides reduce hunger the way a GLP-1 does.
3. Net energy balance still rules. GH-driven lipolysis releases fatty acids, but if you're in a surplus those fatty acids get re-stored. Without a deficit, the GH effect doesn't translate into actual fat loss.

This is the most common disappointment in the category — users expect Ipamorelin or CJC-1295 to drive weight loss without diet changes, see no scale movement, and conclude their peptides don't work. The peptides are working. The deficit isn't there.

What GH peptides actually do for fat loss

When stacked on top of a real cut, the contributions are:

The biggest practical wins for most users:

• You hold more muscle in the deficit. Cuts on GH peptides typically preserve strength and lean mass better than unassisted cuts.
• The visceral fat goes first. Stubborn abdominal/visceral fat tends to reduce noticeably, especially on Tesamorelin or longer Ipa+CJC runs.
• Recovery doesn't tank. Aggressive cuts usually wreck training capacity; on GH peptides this is muted.

Visceral vs subcutaneous

Tesamorelin's clinical record is in visceral adipose tissue reduction (the original FDA approval was for HIV-associated lipodystrophy). The mechanism translates to non-HIV users — visceral fat is more GH-receptor-rich and more responsive to GH-axis activation than subcutaneous fat.

Practical implication: GH peptides are particularly useful for users carrying excess visceral fat (the harder-to-shift abdominal fat that doesn't always correlate with overall body fat percentage). They're less differentiated for general subcutaneous fat loss.

See Tesamorelin protocol for the strongest visceral fat data in the category.

Compared to GLP-1s

GLP-1 receptor agonists (semaglutide, tirzepatide) are an entirely different mechanism. They drive weight loss primarily by:

• Appetite suppression (the dominant mechanism)
• Slowed gastric emptying
• Improved insulin sensitivity

These are not competing tools — they solve different problems. GLP-1s drive weight loss but often at the cost of meaningful lean mass. GH peptides preserve muscle but don't drive weight loss on their own.

A combined approach (GLP-1 for weight, GH peptide for muscle preservation) is increasingly common but should be discussed with a clinician — there's not a lot of data on the combination yet.

How to stack GH peptides into a fat-loss protocol

A reasonable structure:

1. Set up the deficit first. A 300–500 calorie daily deficit with high protein (1g per pound of bodyweight or close to it). This is the engine.
2. Train for muscle retention. Continue heavy compound lifting; reduce volume modestly if recovery suffers.
3. Add the secretagogue. Ipa+CJC pre-bed (and optionally pre/post training), or Tesamorelin daily for stronger visceral targeting.
4. Bias cardio for fat loss. GH peptides work synergistically with fasted morning cardio (low-intensity, 20–40 minutes) — the GH-driven lipolysis pairs well with fasted-state fatty-acid use.
5. Track IGF-1 and bloodwork. See IGF-1 testing on a GH peptide cycle.
6. Run 12–16 weeks. Body composition changes from GH peptides need time.

What not to expect

• Rapid weight loss. GH peptides don't drive scale movement directly.
• Visible recomp without diet changes. The peptide is the multiplier, not the engine.
• Appetite reduction. Not happening on Ipa or CJC; reversed on GHRP-6.
• HGH-level results. Secretagogues cap below synthetic HGH for both fat loss and muscle effects.

Honest framing

If you're carrying significant excess body fat and want to lose it, the highest-leverage intervention is a calorie deficit, high protein, and consistent resistance training. GH peptides on top of that protocol amplify your muscle retention and bias the fat loss toward visceral stores. Without the underlying protocol, they don't do much.

If you're already lean and trying to optimize body composition at the margins, GH peptides are well-suited — small differences accumulate over a 12–16 week cycle.

Related reading

• Tesamorelin protocol
• Ipamorelin protocol
• GH secretagogues vs synthetic HGH
• IGF-1 testing on a GH peptide cycle